175 related articles for article (PubMed ID: 29458117)
1. Agomelatine's effect on circadian locomotor rhythm alteration and depressive-like behavior in 6-OHDA lesioned rats.
Souza LC; Martynhak BJ; Bassani TB; Turnes JM; Machado MM; Moura E; Andreatini R; Vital MABF
Physiol Behav; 2018 May; 188():298-310. PubMed ID: 29458117
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study.
Boulamery A; Simon N; Vidal J; Bruguerolle B
Chronobiol Int; 2010 Jan; 27(2):251-64. PubMed ID: 20370468
[TBL] [Abstract][Full Text] [Related]
3. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
[TBL] [Abstract][Full Text] [Related]
4. Consequences of long-term treatment with agomelatine on depressive-like behavior and neurobiological abnormalities in pinealectomized rats.
Tchekalarova J; Nenchovska Z; Atanasova D; Atanasova M; Kortenska L; Stefanova M; Alova L; Lazarov N
Behav Brain Res; 2016 Apr; 302():11-28. PubMed ID: 26779670
[TBL] [Abstract][Full Text] [Related]
5. Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light.
Tchekalarova J; Stoynova T; Ilieva K; Mitreva R; Atanasova M
Pharmacol Biochem Behav; 2018 Aug; 171():1-9. PubMed ID: 29807067
[TBL] [Abstract][Full Text] [Related]
6. Disturbances of diurnal phase markers, behavior, and clock genes in a rat model of depression; modulatory effects of agomelatine treatment.
Højgaard K; Christiansen SL; Bouzinova EV; Wiborg O
Psychopharmacology (Berl); 2018 Mar; 235(3):627-640. PubMed ID: 29151193
[TBL] [Abstract][Full Text] [Related]
7. Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT
Tchekalarova J; Kortenska L; Ivanova N; Atanasova M; Marinov P
Psychopharmacology (Berl); 2020 Feb; 237(2):503-518. PubMed ID: 31720718
[TBL] [Abstract][Full Text] [Related]
8. [Development of a new antidepressant : agomelatine].
Mocaër E; Delalleau B; Boyer PA; de Bodinat C
Med Sci (Paris); 2005 Oct; 21(10):888-93. PubMed ID: 16197911
[TBL] [Abstract][Full Text] [Related]
9. Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.
Tadaiesky MT; Dombrowski PA; Figueiredo CP; Cargnin-Ferreira E; Da Cunha C; Takahashi RN
Neuroscience; 2008 Oct; 156(4):830-40. PubMed ID: 18817851
[TBL] [Abstract][Full Text] [Related]
10. Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system.
San L; Arranz B
Eur Psychiatry; 2008 Sep; 23(6):396-402. PubMed ID: 18583104
[TBL] [Abstract][Full Text] [Related]
11. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
[TBL] [Abstract][Full Text] [Related]
12. Circadian distribution of motor-activity in unilaterally 6-hydroxy-dopamine lesioned rats.
Baier PC; Branisa P; Koch R; Schindehütte J; Paulus W; Trenkwalder C
Exp Brain Res; 2006 Feb; 169(2):283-8. PubMed ID: 16432693
[TBL] [Abstract][Full Text] [Related]
13. Agomelatine as chronopsychopharmaceutics restoring circadian rhythms and enhancing resilience to stress: a wishfull thinking or an innovative strategy for superior management of depression?
Jakovljević M
Psychiatr Danub; 2011 Mar; 23(1):2-9. PubMed ID: 21448091
[TBL] [Abstract][Full Text] [Related]
14. Temporal Dissociation of Striatum and Prefrontal Cortex Uncouples Anhedonia and Defense Behaviors Relevant to Depression in 6-OHDA-Lesioned Rats.
Matheus FC; Rial D; Real JI; Lemos C; Takahashi RN; Bertoglio LJ; Cunha RA; Prediger RD
Mol Neurobiol; 2016 Aug; 53(6):3891-3899. PubMed ID: 26164273
[TBL] [Abstract][Full Text] [Related]
15. Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats.
Mairesse J; Silletti V; Laloux C; Zuena AR; Giovine A; Consolazione M; van Camp G; Malagodi M; Gaetani S; Cianci S; Catalani A; Mennuni G; Mazzetta A; van Reeth O; Gabriel C; Mocaër E; Nicoletti F; Morley-Fletcher S; Maccari S
Int J Neuropsychopharmacol; 2013 Mar; 16(2):323-38. PubMed ID: 22310059
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.
Harkavyi A; Abuirmeileh A; Lever R; Kingsbury AE; Biggs CS; Whitton PS
J Neuroinflammation; 2008 May; 5():19. PubMed ID: 18492290
[TBL] [Abstract][Full Text] [Related]
17. [Agomelatine: the first "melatoninergic" antidepressant].
Bánki MC
Neuropsychopharmacol Hung; 2006 Oct; 8(3):105-12. PubMed ID: 17211046
[TBL] [Abstract][Full Text] [Related]
18. Agomelatine protects against neuronal damage without preventing epileptogenesis in the kainate model of temporal lobe epilepsy.
Tchekalarova J; Atanasova D; Nenchovska Z; Atanasova M; Kortenska L; Gesheva R; Lazarov N
Neurobiol Dis; 2017 Aug; 104():1-14. PubMed ID: 28438504
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats.
Lima LAR; Lopes MJP; Costa RO; Lima FAV; Neves KRT; Calou IBF; Andrade GM; Viana GSB
J Neuroinflammation; 2018 Aug; 15(1):249. PubMed ID: 30170624
[TBL] [Abstract][Full Text] [Related]
20. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
Machado-Filho JA; Correia AO; Montenegro AB; Nobre ME; Cerqueira GS; Neves KR; Naffah-Mazzacoratti Mda G; Cavalheiro EA; de Castro Brito GA; de Barros Viana GS
Behav Brain Res; 2014 May; 264():116-25. PubMed ID: 24525422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
